NCT04721457View on ClinicalTrials.gov

The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 3, 2021

Primary Completion Date

March 28, 2021

Study Completion Date

December 10, 2021

Conditions
SARS-CoV-2COVID-19MouthwashesViral LoadPolymerase Chain ReactionCoronavirusCovid19Saliva
Interventions
DRUG

Distilled Water

Control group

DRUG

1% Povidone Iodine (PVP-I)

Over-the-counter antiseptic mouth rinse

DRUG

1.5% Hydrogen Peroxide (H2O2)

Over-the-counter antiseptic mouth rinse

DRUG

0.075% Cetylpyridinium Chloride (CPC)

Over-the-counter antiseptic mouth rinse

DRUG

0.1% Sodium Hypochlorite

Over-the-counter antiseptic mouth rinse

OTHER

No rinse group

second control group

Trial Locations (1)

Unknown

Alhamra TETAMMAN clinic (PHC), Jeddah

All Listed Sponsors
lead

King Abdulaziz University

OTHER

NCT04721457 - The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load | Biotech Hunter | Biotech Hunter